Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. - Wang,J.; Iwasaki,H.; Krivtsov,A.; Febbo,PG.; Thorner,AR.; Ernst,P.; Anastasiadou,E.; Kutok,JL.; Kogan,SC.; Zinkel,SS.; Fisher,JK.; Hess,JL.; et al. (Embo J, 2005)